BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23620537)

  • 1. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout.
    Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu EQ; Tawk R; Liu J; Shi L
    QJM; 2013 Aug; 106(8):721-9. PubMed ID: 23620537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum urate and incidence of kidney disease among veterans with gout.
    Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu E; Tawk RH; Liu J; Shi L
    J Rheumatol; 2013 Jul; 40(7):1166-72. PubMed ID: 23678154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data.
    Essex MN; Hopps M; Bienen EJ; Udall M; Mardekian J; Makinson GT
    J Clin Rheumatol; 2017 Apr; 23(3):160-166. PubMed ID: 28248798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.
    Dalbeth N; Phipps-Green A; Frampton C; Neogi T; Taylor WJ; Merriman TR
    Ann Rheum Dis; 2018 Jul; 77(7):1048-1052. PubMed ID: 29463518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.
    Juraschek SP; Appel LJ; Miller ER
    Am J Hypertens; 2017 Sep; 30(9):871-875. PubMed ID: 28830083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Specific Association of Serum Uric Acid Level and Change in Hyperuricemia Status with Risk of Type 2 Diabetes Mellitus: A Large Cohort Study in China.
    Lou Y; Qin P; Wang C; Ma J; Peng X; Xu S; Chen H; Zhao D; Wang L; Liu D; Li Y; Zhao P; Han D; Hu D; Hu F
    J Diabetes Res; 2020; 2020():9637365. PubMed ID: 32775463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney in hyperuricemia and gout.
    Mount DB
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
    Becker MA; Schumacher HR; Espinoza LR; Wells AF; MacDonald P; Lloyd E; Lademacher C
    Arthritis Res Ther; 2010; 12(2):R63. PubMed ID: 20370912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout.
    Carnicelli AP; Clare R; Chiswell K; Lytle B; Bjursell M; Perl S; Andersson K; Hedman K; Pagidipati N; Vemulapalli S; Roe MT; Mentz RJ
    Am J Cardiol; 2020 Jul; 127():64-72. PubMed ID: 32386813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
    Levy GD; Rashid N; Niu F; Cheetham TC
    J Rheumatol; 2014 May; 41(5):955-62. PubMed ID: 24692523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index.
    Reynolds RJ; Vazquez AI; Srinivasasainagendra V; Klimentidis YC; Bridges SL; Allison DB; Singh JA
    Rheumatol Int; 2016 Feb; 36(2):263-70. PubMed ID: 26427508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality predictive role of serum uric acid in diabetic hemodialysis patients.
    Jeon JS; Chung SH; Han DC; Noh H; Kwon SH; Lindholm B; Lee HB
    J Ren Nutr; 2014 Sep; 24(5):336-42. PubMed ID: 25167998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan.
    Koto R; Nakajima A; Horiuchi H; Yamanaka H
    Ann Rheum Dis; 2021 Nov; 80(11):1483-1490. PubMed ID: 34158371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
    Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
    RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
    Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
    Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.
    Tanaka A; Taguchi I; Teragawa H; Ishizaka N; Kanzaki Y; Tomiyama H; Sata M; Sezai A; Eguchi K; Kato T; Toyoda S; Ishibashi R; Kario K; Ishizu T; Ueda S; Maemura K; Higashi Y; Yamada H; Ohishi M; Yokote K; Murohara T; Oyama JI; Node K;
    PLoS Med; 2020 Apr; 17(4):e1003095. PubMed ID: 32320401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
    Bjornstad P; Laffel L; Lynch J; El Ghormli L; Weinstock RS; Tollefsen SE; Nadeau KJ;
    Diabetes Care; 2019 Jun; 42(6):1120-1128. PubMed ID: 30967435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Kuwabara M; Niwa K; Nishihara S; Nishi Y; Takahashi O; Kario K; Yamamoto K; Yamashita T; Hisatome I
    Int J Cardiol; 2017 Mar; 231():137-142. PubMed ID: 27871785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.